论文研究中理论与实践相结合，首先对国内制药行业现状与企业药品研发战略研
究情况进行回顾，其次运用企业竞争力理论、战略管理理论、产品生命周期理论，分
析了 EY 制药药品研发的内部优势和劣势及面临外部的竞争环境，按照利用内部优势
资源和外部机会，回避内部劣势和外部威胁的思路，提出了 EY 制药的药品研发战略：
在新产品选择上，重点先开发市场前景好的仿制药和对已有品种的二次开发，再开发
相对容易成功的“me 一 too”药物，最终实现完全创新品种的研发；在药品研发模式上，
可以根据不同情形选择联合研发与自主研发，需特别重视与 CRO 公司合作；三是在
研发投入机制上，可以实行多渠道融资形式，获取研发资金。同时提出了 EY 制药药
品研发的战略重点，为战略实施提供原则性指导，最后制定出详细的药品研发战略实
施步骤，以及 EY 制药药品研发战略实施的配套保障措施。
药品研发战略是制药企业发展战略的重要组成部分，论文尝试帮助 EY 制药制定
药品研发战略，并制定措施保障战略实施，给企业在研发方向选择上给予明确指导，
从而实现企业的发展战略规划，也为国内其他中小制药企业战略制定提供参考，为促
进我国医药产业的做大做强尽一份努力。
关键词：制药企业 药品研发战略
作 者：陈园园
指导教师：顾建平Abstract EY pharmaceutical R & D strategy study
II
EY pharmaceutical R & D strategy study
Abstract
At present， small and medium-sized pharmaceutical enterprises in China accounted
for the vast majority of the total number of pharmaceutical companies，pharmaceutical
research and development is more generic drug variety ， lack of planning and
strategic system， small and medium enterprises how to formulate and implement the
strategy of drug development ， realize the variety innovation to gain competitive
advantage，at present this study is less，this analysis and research the EY pharmaceutical
R&D condition ， put forward EY pharmaceutical drug development strategy and
guarantee measures.
The theory and practice of combining the current situation and enterprise drug
development strategy research situation of the domestic pharmaceutical industryis
reviewed， followed by the use of the theory of enterprise competitiveness，strategic
management theory， the product life cycle theory， analyzes the EY pharmaceutical drug
development of internal strengths and weaknesses and the external competitive
environment， in accordance with the use of internal resources advantages and the external
opportunities ， avoiding internal weaknesses and external threats ideas ， put
forward EY pharmaceutical drug development strategy: in the new product
selection ， key to the development of good market prospect of generic drugs
and the varieties of two development，development is relatively easy to the success of
me- too drugs ， and ultimately developed completely innovative varieties; in drug
development ， according to the different situation choice of joint research and
development with independent research and development， should pay special attention
to cooperation with the CRO company; the three is the input mechanism of R&D， can
implement multi-channel financing， acquisition of R&D funds. At the same time put
forward strategic focus two leaves pharmaceutical drug development， provide principled
guidance for the implementation of the strategy， finally make the pharmaceutical R&D
==>>